Control of cardiovascular risk factors with tailored recommendations: A randomized controlled trial

dc.contributor.authorBarroso, María
dc.contributor.authorZomeño Fajardo, María Dolores
dc.contributor.authorDíaz, Jorge Luis
dc.contributor.authorPérez-Fernández, Silvia
dc.contributor.authorMartí Lluch, Ruth
dc.contributor.authorCordón Granados, Ferran
dc.contributor.authorRamos, Rafel
dc.contributor.authorCabezas Peña, Carmen
dc.contributor.authorSalvador, Gemma
dc.contributor.authorCastell, Contxa
dc.contributor.authorSchröder, Helmut, 1958-
dc.contributor.authorGrau, Maria
dc.date.accessioned2026-10-22T09:07:33Z
dc.date.available2026-10-22T09:07:33Z
dc.date.issued2020-11-02
dc.date.updated2026-10-22T09:07:37Z
dc.description.abstractThis study analyzed the efficacy of tailored recommendations to control cardiovascular risk factors at 1-year follow-up in a population-based randomized controlled trial in individuals aged 35-74 years with no history of cardiovascular disease at baseline. Total, low-density lipoprotein (LDL), and high-density lipoprotein cholesterol and systolic and diastolic blood pressure (BP) were measured at baseline and at 1-year follow-up. The primary outcome was the quantitative change in total cholesterol. To estimate the differences within and between groups, McNemar and Student t-tests were applied according to an intention-to-treat strategy. We enrolled 955 individuals [52.3% women; mean age, 50 years (standard deviation 10)]. Finally, 1 participant in each group presented a cardiovascular event and 768 were reexamined at 1-year follow-up. Intervention and control groups showed significant increases in total cholesterol [5.49 (standard deviation 1.02) to 5.56 (1.06) mmol/L and 5.34 (0.94) to 5.43 (0.93) mmol/L, respectively]. Men in the intervention group showed significant decreases in systolic and diastolic BP [117.2 (14.6) to 115.6 mmHg (14.1) and 77.9 (9.7) to 76.5 mmHg (9.7), respectively]; no changes were found in the rates of total cholesterol <5.2 mmol/L and LDL cholesterol <3.0 mmol/L. In the control group, both values were significantly decreased (43.5 to 36.4% and 26.4 to 20.8%, respectively) in men. In the stratified analysis, women showed no differences in any of the outcomes. In conclusion, an intervention with tailored recommendations increased mean total cholesterol values. The intervention effect was higher in men who maintained blood lipids at optimal levels and had decreased BP values.
dc.format.extent50 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec705825
dc.identifier.issn0091-7435
dc.identifier.urihttps://hdl.handle.net/2445/232246
dc.language.isoeng
dc.publisherElsevier
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.ypmed.2020.106302
dc.relation.ispartofPreventive Medicine, 2020, vol. 141
dc.relation.urihttps://doi.org/10.1016/j.ypmed.2020.106302
dc.rightscc-by-nc-nd (c) Elsevier, 2020
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.classificationPressió sanguínia
dc.subject.classificationMalalties cardiovasculars
dc.subject.classificationDiabetis
dc.subject.classificationLípids
dc.subject.otherBlood pressure
dc.subject.otherCardiovascular diseases
dc.subject.otherDiabetes
dc.subject.otherLipids
dc.titleControl of cardiovascular risk factors with tailored recommendations: A randomized controlled trial
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
233418.pdf
Mida:
7.88 MB
Format:
Adobe Portable Document Format